Regulatory analysis on the medical use of ephedrine-related products in Taiwan

Research output: Contribution to journalArticle

Abstract

To prevent ephedrine-related products from being misused to produce amphetamine and/or its analogs, there's a need for more effective and achievable regulatory mechanisms for the health, police, investigational, prosecution and judiciary authorities in Taiwan. This review was conducted to evaluate the international and Taiwan's regulatory policies and management of medical ephedrine-related products through the corresponding information collected from international and Taiwan government agency authorities. The combat of illegal drugs should involve both supply and demand sides to be successful. Health authorities in Taiwan do not have the investigational power to manage the forbidden transformation, abusing and manufacture of the illegal drugs from ephedrine-related products. Take the judicial interventions in the United States and in Japan as the examples, the organizational cooperation in Taiwan can be one of the main key strategies to combat against illegal drugs from ephedrine-related products. It is necessary to integrate the judicial, police and health agencies to prevent the production of illegal drugs from the ephedrine-related products in Taiwan. The efforts and regulatory control measures should be integrated to speed up the collaboration between different government authorities. It might be achieved through reorganization involving Taiwan Food and Drug Administration.

Original languageEnglish
JournalJournal of Food and Drug Analysis
Volume26
Issue number2
DOIs
Publication statusPublished - Apr 2018

Fingerprint

ephedrine
Ephedrine
Taiwan
police
drugs
Police
Pharmaceutical Preparations
Health
amphetamine
Government Agencies
government agencies
supply balance
Amphetamine
United States Food and Drug Administration
control methods
Japan
manufacturing

Keywords

  • Controlled Drugs Act
  • Ephedrine-related products
  • Pharmaceutical Affairs Act
  • Pharmacists Act
  • Taiwan Food and Drug Administration (TFDA)

ASJC Scopus subject areas

  • Food Science
  • Pharmacology

Cite this

Regulatory analysis on the medical use of ephedrine-related products in Taiwan. / Yu, Wan Nan; Wang, Li Hsuan; Cheng, Hui Wen.

In: Journal of Food and Drug Analysis, Vol. 26, No. 2, 04.2018.

Research output: Contribution to journalArticle

@article{ec437b9d99454c8ab458766ad644f2e6,
title = "Regulatory analysis on the medical use of ephedrine-related products in Taiwan",
abstract = "To prevent ephedrine-related products from being misused to produce amphetamine and/or its analogs, there's a need for more effective and achievable regulatory mechanisms for the health, police, investigational, prosecution and judiciary authorities in Taiwan. This review was conducted to evaluate the international and Taiwan's regulatory policies and management of medical ephedrine-related products through the corresponding information collected from international and Taiwan government agency authorities. The combat of illegal drugs should involve both supply and demand sides to be successful. Health authorities in Taiwan do not have the investigational power to manage the forbidden transformation, abusing and manufacture of the illegal drugs from ephedrine-related products. Take the judicial interventions in the United States and in Japan as the examples, the organizational cooperation in Taiwan can be one of the main key strategies to combat against illegal drugs from ephedrine-related products. It is necessary to integrate the judicial, police and health agencies to prevent the production of illegal drugs from the ephedrine-related products in Taiwan. The efforts and regulatory control measures should be integrated to speed up the collaboration between different government authorities. It might be achieved through reorganization involving Taiwan Food and Drug Administration.",
keywords = "Controlled Drugs Act, Ephedrine-related products, Pharmaceutical Affairs Act, Pharmacists Act, Taiwan Food and Drug Administration (TFDA)",
author = "Yu, {Wan Nan} and Wang, {Li Hsuan} and Cheng, {Hui Wen}",
year = "2018",
month = "4",
doi = "10.1016/j.jfda.2017.11.002",
language = "English",
volume = "26",
journal = "Journal of Food and Drug Analysis",
issn = "1021-9498",
publisher = "Elsevier Taiwan LLC",
number = "2",

}

TY - JOUR

T1 - Regulatory analysis on the medical use of ephedrine-related products in Taiwan

AU - Yu, Wan Nan

AU - Wang, Li Hsuan

AU - Cheng, Hui Wen

PY - 2018/4

Y1 - 2018/4

N2 - To prevent ephedrine-related products from being misused to produce amphetamine and/or its analogs, there's a need for more effective and achievable regulatory mechanisms for the health, police, investigational, prosecution and judiciary authorities in Taiwan. This review was conducted to evaluate the international and Taiwan's regulatory policies and management of medical ephedrine-related products through the corresponding information collected from international and Taiwan government agency authorities. The combat of illegal drugs should involve both supply and demand sides to be successful. Health authorities in Taiwan do not have the investigational power to manage the forbidden transformation, abusing and manufacture of the illegal drugs from ephedrine-related products. Take the judicial interventions in the United States and in Japan as the examples, the organizational cooperation in Taiwan can be one of the main key strategies to combat against illegal drugs from ephedrine-related products. It is necessary to integrate the judicial, police and health agencies to prevent the production of illegal drugs from the ephedrine-related products in Taiwan. The efforts and regulatory control measures should be integrated to speed up the collaboration between different government authorities. It might be achieved through reorganization involving Taiwan Food and Drug Administration.

AB - To prevent ephedrine-related products from being misused to produce amphetamine and/or its analogs, there's a need for more effective and achievable regulatory mechanisms for the health, police, investigational, prosecution and judiciary authorities in Taiwan. This review was conducted to evaluate the international and Taiwan's regulatory policies and management of medical ephedrine-related products through the corresponding information collected from international and Taiwan government agency authorities. The combat of illegal drugs should involve both supply and demand sides to be successful. Health authorities in Taiwan do not have the investigational power to manage the forbidden transformation, abusing and manufacture of the illegal drugs from ephedrine-related products. Take the judicial interventions in the United States and in Japan as the examples, the organizational cooperation in Taiwan can be one of the main key strategies to combat against illegal drugs from ephedrine-related products. It is necessary to integrate the judicial, police and health agencies to prevent the production of illegal drugs from the ephedrine-related products in Taiwan. The efforts and regulatory control measures should be integrated to speed up the collaboration between different government authorities. It might be achieved through reorganization involving Taiwan Food and Drug Administration.

KW - Controlled Drugs Act

KW - Ephedrine-related products

KW - Pharmaceutical Affairs Act

KW - Pharmacists Act

KW - Taiwan Food and Drug Administration (TFDA)

UR - http://www.scopus.com/inward/record.url?scp=85036636130&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85036636130&partnerID=8YFLogxK

U2 - 10.1016/j.jfda.2017.11.002

DO - 10.1016/j.jfda.2017.11.002

M3 - Article

VL - 26

JO - Journal of Food and Drug Analysis

JF - Journal of Food and Drug Analysis

SN - 1021-9498

IS - 2

ER -